Trogarzo 200 MG/1.33 ML vial 1.33ML
Ended Awarded
- Contract number
- SPE2DB25FPRN6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,760
Award facts
- Contract value 100% obligated
- $49,759.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49.76K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trogarzo 200 mg/1.33 ml vials. The contract, which carries no set-aside designation, was awarded on September 22, 2025, with an ultimate completion date of October 14, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500M through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure multiple contracts with DLA for branded and generic prescription drugs, biologics, vaccines, and specialty medications. Trogarzo, an HIV integrase strand transfer inhibitor, represents the type of specialty pharmaceutical product that DMS regularly distributes to Department of Defense healthcare sites. The firm fixed-price structure and compressed delivery timeline reflect the urgency of medical supply requirements across military healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FPRN6?
SPE2DB25FPRN6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FPRN6 worth?
The government has obligated $49,760 on SPE2DB25FPRN6.
Is contract SPE2DB25FPRN6 an order under another contract?
Yes. SPE2DB25FPRN6 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRN6 competed?
The extent of competition for SPE2DB25FPRN6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award